A Randomized, Open-Label Trial of RISPERDAL CONSTA Versus Oral Antipsychotic Care in Subjects With Bipolar Disorder
Phase of Trial: Phase III
Latest Information Update: 10 Feb 2011
At a glance
- Drugs Risperidone (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Janssen Inc
- 19 Oct 2007 Status changed from in progress to completed.
- 08 Aug 2006 Status change
- 01 Mar 2006 New trial record.